Malaria - Pipeline Review, H2 2014

Global Markets Direct
July 31, 2014
394 Pages - SKU: GMD5310039
Alcoholic Hepatitis - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Alcoholic Hepatitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H2 2014’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic  |  read more...
USD 2,000
Corneal Graft Rejection - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Corneal Graft Rejection - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Corneal Graft Rejection - Pipeline Review, H2 2014’, provides an overview of the Corneal Graft Rejection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Gonorrhea - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Gonorrhea - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gonorrhea, complete with comparative  |  read more...
USD 2,000
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014’, provides an overview of the Nerve Gas & Pestiside Poisioning’s therapeutic pipeline. This report  |  read more...
USD 2,000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Premature Labor (Tocolysis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Pipeline Review, H2 2014’, provides an overview of the Premature Labor (Tocolysis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2014’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic pipeline. This report  |  read more...
USD 2,000
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction  |  read more...
USD 3,995
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2014’, provides an overview of the Proliferative Diabetic Retinopathy (PDR)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)’s  |  read more...
USD 2,000
Mycosis Fungoides - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Mycosis Fungoides - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mycosis  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!